Merks JHM - Search Results

1

Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Gallego S, Zanetti I, Orbach D, Ranchère D, Shipley J, Zin A, Bergeron C, de Salvo GL, Chisholm J, Ferrari A, Jenney M, Mandeville HC, Rogers T, Merks JHM, Mudry P, Glosli H, Milano GM, Ferman S, Bisogno G; European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Gallego S, et al. Among authors: merks jhm. Cancer. 2018 Aug 1;124(15):3201-3209. doi: 10.1002/cncr.31553. Epub 2018 May 24. Cancer. 2018. PMID: 29797665 Free article.

2

A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol.

Buwalda J, Schouwenburg PF, Blank LE, Merks JH, Copper MP, Strackee SD, Voûte PA, Caron HN. Buwalda J, et al. Eur J Cancer. 2003 Jul;39(11):1594-602. doi: 10.1016/s0959-8049(03)00363-0. Eur J Cancer. 2003. PMID: 12855267

3

Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.

Casanova M, Ferrari A, Bisogno G, Merks JH, De Salvo GL, Meazza C, Tettoni K, Provenzi M, Mazzarino I, Carli M. Casanova M, et al. Cancer. 2004 Oct 1;101(7):1664-71. doi: 10.1002/cncr.20544. Cancer. 2004. PMID: 15378498 Free article.

4

High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma.

Admiraal R, van der Paardt M, Kobes J, Kremer LC, Bisogno G, Merks JH. Admiraal R, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006669. doi: 10.1002/14651858.CD006669.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154373 Review.

5

Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy.

Chisholm JC, Marandet J, Rey A, Scopinaro M, de Toledo JS, Merks JH, O'Meara A, Stevens MC, Oberlin O. Chisholm JC, et al. J Clin Oncol. 2011 Apr 1;29(10):1319-25. doi: 10.1200/JCO.2010.32.1984. Epub 2011 Feb 28. J Clin Oncol. 2011. PMID: 21357778 Clinical Trial.

6

Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.

Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, Bergeron C, Merks JH, Bouvet N, Ellershaw C, Kelsey A, Spooner D, Stevens MC. Oberlin O, et al. J Clin Oncol. 2012 Jul 10;30(20):2457-65. doi: 10.1200/JCO.2011.40.3287. Epub 2012 Jun 4. J Clin Oncol. 2012. PMID: 22665534 Clinical Trial.

7

Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?

Schoot RA, McHugh K, van Rijn RR, Kremer LC, Chisholm JC, Caron HN, Merks JH. Schoot RA, et al. Radiology. 2013 Dec;269(3):870-8. doi: 10.1148/radiol.13122607. Epub 2013 Oct 28. Radiology. 2013. PMID: 23985275

8

Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.

Jenney M, Oberlin O, Audry G, Stevens MC, Rey A, Merks JH, Kelsey A, Gallego S, Haie-Meder C, Martelli H. Jenney M, et al. Pediatr Blood Cancer. 2014 Feb;61(2):217-22. doi: 10.1002/pbc.24727. Epub 2013 Aug 29. Pediatr Blood Cancer. 2014. PMID: 23997024

9

Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

Merks JH, De Salvo GL, Bergeron C, Bisogno G, De Paoli A, Ferrari A, Rey A, Oberlin O, Stevens MC, Kelsey A, Michalski J, Hawkins DS, Anderson JR. Merks JH, et al. Ann Oncol. 2014 Jan;25(1):231-6. doi: 10.1093/annonc/mdt426. Ann Oncol. 2014. PMID: 24356633 Free PMC article.

10

Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.

Terwisscha van Scheltinga CE, Spronk P, van Rosmalen J, Wijnen MH, Heij HA, van Baren R, Merks JH, van Noesel MM, Wijnen RM. Terwisscha van Scheltinga CE, et al. J Pediatr Surg. 2014 Mar;49(3):416-9. doi: 10.1016/j.jpedsurg.2013.08.002. J Pediatr Surg. 2014. PMID: 24650468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page